Literature DB >> 26685011

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis.

S Bracarda, R Iacovelli, L Boni, M Rizzo, L Derosa, M Rossi, L Galli, G Procopio, M Sisani, F Longo, M Santoni, F Morelli, G Di Lorenzo, A Altavilla, C Porta, A Camerini, B Escudier.   

Abstract

Entities:  

Year:  2015        PMID： 26685011     DOI： 10.1093/annonc/mdv589

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.

Authors:  Robert J Motzer; Bernard Escudier; Andrew Gannon; Robert A Figlin
Journal:  Oncologist       Date:  2016-11-02

2.  Metastatic Clear Cell Renal Cell Carcinoma to Pancreas and Distant Organs 24 Years After Radical Nephrectomy: A Case Report and Literature Review.

Authors:  Huawei Cao; Zejia Sun; Jiyue Wu; Changzhen Hao; Wei Wang
Journal:  Front Surg       Date:  2022-07-05

Review 3.  Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma.

Authors:  Kevin Zarrabi; Shenhong Wu
Journal:  Curr Oncol Rep       Date:  2018-04-02       Impact factor: 5.075

4.  Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Authors:  Gaetano Facchini; Sabrina Rossetti; Massimiliano Berretta; Carla Cavaliere; Sarah Scagliarini; Maria Giuseppa Vitale; Chiara Ciccarese; Giuseppe Di Lorenzo; Erica Palesandro; Vincenza Conteduca; Umberto Basso; Emanuele Naglieri; Azzurra Farnesi; Michele Aieta; Nicolò Borsellino; Leonardo La Torre; Gelsomina Iovane; Lucia Bonomi; Donatello Gasparro; Enrico Ricevuto; Michele De Tursi; Rocco De Vivo; Giovanni Lo Re; Francesco Grillone; Paolo Marchetti; Ferdinando De Vita; Claudio Scavelli; Claudio Sini; Salvatore Pisconti; Anna Crispo; Vittorio Gebbia; Antonio Maestri; Luca Galli; Ugo De Giorgi; Roberto Iacovelli; Carlo Buonerba; Giacomo Cartenì; Carmine D'Aniello
Journal:  J Transl Med       Date:  2019-08-29       Impact factor: 5.531

5.  Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.

Authors:  Qinke Li; Wenbo Yang; Maoqing Lu; Ronggui Zhang
Journal:  Med Sci Monit       Date:  2020-12-09

6.  Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Anikó Maráz; Adrienn Cserháti; Gabriella Uhercsák; Éva Szilágyi; Zoltán Varga; János Révész; Renáta Kószó; Linda Varga; Zsuzsanna Kahán
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.